Home Search
cannabis - search results
If you're not happy with the results, please do another search
The priorities for cannabis research
Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
The UK’s clinicians need training in medical cannabis – here’s why
Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
Research finds cannabis could reduce OCD symptoms by 50%
OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
EUMCA: Medical cannabis and research collaboration after Brexit
Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
Ensuring a high and reproducible quality of medicinal cannabis
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
The import of medical cannabis: Germany and the Netherlands
Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
Chronic pain diseases and medical cannabis
Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.
How are different types of medical cannabis working for different diseases?
Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
The EUMCA: Pioneering access to medicinal cannabis
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
The medical cannabis space: A successful targeted investment strategy
In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
The export of medicinal cannabis from Israel
Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.
COVID-19: A moment for legalising medical cannabis?
Here, Josh Smith talks us through the current pandemic and the recent history underlying the fight for legalising medical cannabis.
COVID-19 and medical cannabis: Could the crisis bring opportunities?
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
Measuring heavy metals in cannabis and hemp
Here, Robert Thomas, Principal Consultant, Scientific Solutions, highlights the importance of measuring metals in cannabis and hemp.
Health Canada: Legalising edible cannabis products
Health Canada led the world in large-scale cannabis legalisation and is now creating regulation for edible cannabis products: What is next?
Growing pains: Creating value in the maturing cannabis market
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
Medical cannabis vaporizers
Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.
Up in smoke: Understanding knowledge gaps for cannabis edibles
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.